Prota Therapeutics
PrivateLast Round
Series A
Extension
Jan 16, 2024
Total Funding Raised
$43.48M
Company Overview
Prota Therapeutics is a biotechnology company that develops and commercializes oral immunotherapy treatments for food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prota Therapeutics Comparables
Compare Prota Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aravax | 87% | |
| Intrommune Therapeutics | 84% | |
| Camallergy | 83% | |
Prota Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 16, 2024 | ||||
| Series A | May 27, 2017 | ||||
| Series A | Sep 1, 2016 |
Key People
Founding team and executive leadership
Prota Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series A Extension, Series A |
| SPRIM Global Investments | Series A Extension |
| SPRIM Global Investments | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2025
Investigational peanut allergy therapy PRT120 mentioned in award announcement.
- Sep 17, 2025
Awarded for joint clinical research with Murdoch Children's Research Institute.
Prota Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prota Therapeutics's valuation, stock price, and market status.